Dynavax Technologies
DVAX
#5096
Rank
ยฃ1.37 B
Marketcap
ยฃ11.73
Share price
0.00%
Change (1 day)
12.37%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -ยฃ27.93 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are ยฃ0.33 Billion. In 2024 the company made an earning of ยฃ28.49 Million, an increase over its 2023 earnings that were of ยฃ1.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ27.93 Million-197.99%
2024 ยฃ28.49 M1475.31%
2023 ยฃ1.8 M-99.2%
2022 ยฃ0.22 B238.78%
2021 ยฃ67.12 M-257.89%
2020 -ยฃ42.52 Million-58.58%
2019 -ยฃ0.11 Billion-9.32%
2018 -ยฃ0.12 Billion60.44%
2017 -ยฃ70.55 Million-15.8%
2016 -ยฃ83.79 Million4.22%
2015 -ยฃ80.39 Million16.54%
2014 -ยฃ68.99 Million37.09%
2013 -ยฃ50.32 Million
2010 -ยฃ36.02 Million214.85%
2009 -ยฃ11.44 Million-37.33%
2008 -ยฃ18.26 Million-66.07%
2007 -ยฃ53.81 Million16.92%
2006 -ยฃ46.02 Million170.36%
2005 -ยฃ17.03 Million33.39%
2004 -ยฃ12.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.22 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.78 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.76 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.48 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.81 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.84 B-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ5.97 B-23,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ0.11 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.21 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel